Stay updated on Brilacidin Efficacy in COVID-19 Hospitalized Clinical Trial
Sign up to get notified when there's something new on the Brilacidin Efficacy in COVID-19 Hospitalized Clinical Trial page.

Latest updates to the Brilacidin Efficacy in COVID-19 Hospitalized Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedFooter/site policy updates: Added 'Revision: v3.3.3' and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.3.2 replaces v3.3.1 on the page; this is a minor version update with no change to study results or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1. This is a software version update and does not modify the Study Results content.SummaryDifference0.0%

- Check46 days agoChange DetectedExpanded results include time-to-recovery and recovery rates through Day 29, mortality, adverse events, and subgroup analyses (CRP, IL-6, viral load, onset timing), with baseline characteristics and 8-point clinical status updates.SummaryDifference5%

- Check61 days agoChange DetectedThe new screenshot shows the same study results page with identical data. Only minor formatting changes are visible; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check89 days agoChange DetectedUpdated page now includes a government funding notice and new version v3.2.0, replacing the old version v3.0.2.SummaryDifference1%

Stay in the know with updates to Brilacidin Efficacy in COVID-19 Hospitalized Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brilacidin Efficacy in COVID-19 Hospitalized Clinical Trial page.